# Kyongbo Pharmaceutical Co., Ltd. - Inspection Records

Source: https://www.globalkeysolutions.net/companies/kyongbo-pharmaceutical-co-ltd/6b8fd90f-4fa3-4c7b-9ed6-a8a8f4b511da

> Inspection records and compliance data for Kyongbo Pharmaceutical Co., Ltd. in Asan, None. Access full analysis and detailed observations.

---

## Details

- Name: Kyongbo Pharmaceutical Co., Ltd.
- FEI Number: 3003773799
- City: Asan
- State: None
- Country Name: Korea (the Republic of)
- Address Line 1: 174 Sirok-Ro
- Zip Code: None
- Business Operations: API MANUFACTURE

## Related Documents

- [FDA Inspection 1295018 - Kyongbo Pharmaceutical Co., Ltd. - 2025-11-11](https://www.globalkeysolutions.net/records/fda_inspections/kyongbo-pharmaceutical-co-ltd/5ccde842-fa1b-48e6-a19e-bf02447ba280) — source: FDA, date: November 11, 2025
- [FDA Inspection 1295018 - Kyongbo Pharmaceutical Co., Ltd. - 2025-11-11](https://www.globalkeysolutions.net/records/fda_inspections/kyongbo-pharmaceutical-co-ltd/c26675f6-c274-473d-bee0-2c61d912cb35) — classification: Voluntary Action Indicated (VAI), source: FDA, date: November 11, 2025
- [FDA Inspection 1112024 - Kyongbo Pharmaceutical Co., Ltd. - 2019-12-06](https://www.globalkeysolutions.net/records/fda_inspections/kyongbo-pharmaceutical-co-ltd/e47f28ad-5913-414d-bd46-7adf78a3cffc) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 6, 2019
- [483 - Kyongbo Pharmaceutical Co., Ltd. - 2019-12-02](https://www.globalkeysolutions.net/records/483/kyongbo-pharmaceutical-co-ltd/724a8112-263e-48b8-b476-8814f8a16da8) — source: FDA, date: December 2, 2019
- [FDA Inspection 1036989 - Kyongbo Pharmaceutical Co., Ltd. - 2017-12-01](https://www.globalkeysolutions.net/records/fda_inspections/kyongbo-pharmaceutical-co-ltd/56e3c3e7-a77a-49a6-97b8-9515a55dc75c) — classification: Voluntary Action Indicated (VAI), source: FDA, date: December 1, 2017
- [FDA Inspection 961652 - Kyongbo Pharmaceutical Co., Ltd. - 2016-02-26](https://www.globalkeysolutions.net/records/fda_inspections/kyongbo-pharmaceutical-co-ltd/267f8277-b77b-4975-b270-250594f78986) — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 26, 2016
- [FDA Inspection 736571 - Kyongbo Pharmaceutical Co., Ltd. - 2011-06-28](https://www.globalkeysolutions.net/records/fda_inspections/kyongbo-pharmaceutical-co-ltd/474fa8a3-d6f1-4e36-bde6-acd95e42761f) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 28, 2011

## Related Companies

- [PolyPeptide Laboratories, Inc.](https://www.globalkeysolutions.net/companies/polypeptide-laboratories-inc/9d05664c-4a42-45cc-81f6-ef85c356ecc1)
- [Sigma-Aldrich Manufacturing LLC](https://www.globalkeysolutions.net/companies/sigma-aldrich-manufacturing-llc/e6637246-5655-4a30-849d-a25e3a5cd06c)
- [Signa S.A. de C.V.](https://www.globalkeysolutions.net/companies/signa-sa-de-cv/378a704e-5acb-49b8-9cd6-32503b29b3fc)
- [Almac Sciences Limited](https://www.globalkeysolutions.net/companies/almac-sciences-limited/90ccdc83-facd-4798-aef2-460034d63adf)
- [MSD International GmbH](https://www.globalkeysolutions.net/companies/msd-international-gmbh/a9448cbd-d3cc-4427-a1d5-22dc511c3c07)
- [SCI Pharmtech Inc.](https://www.globalkeysolutions.net/companies/sci-pharmtech-inc/38edf740-19b5-4fbf-bd65-e8cd87a7b1db)
- [AmbioPharm, Inc](https://www.globalkeysolutions.net/companies/ambiopharm-inc/6a51f093-2f5b-433d-8e97-8e33820a50bf)
- [SAFC, Inc.](https://www.globalkeysolutions.net/companies/safc-inc/8b9b439f-c427-4b43-85d2-81ce982736be)
- [Partner Therapeutics Inc](https://www.globalkeysolutions.net/companies/partner-therapeutics-inc/837081c1-0ffa-4c06-94c1-4ce65e130882)
- [Jiangsu Jiaerke Pharmaceuticals Group Corp., Ltd.](https://www.globalkeysolutions.net/companies/jiangsu-jiaerke-pharmaceuticals-group-corp-ltd/7ccd91ae-2b6a-43f7-acc5-6c182cec0d11)

## Related Officers

- [Stephanie A. Slater](https://www.globalkeysolutions.net/people/stephanie-a-slater/f356e65c-3398-4688-8b86-4dcd4b9ae83b)